Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Chuen Li

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Expert Opinion on Pharmacotherapy|July 31, 2007
How to improve pharmacoeconomic data generalisability between different countriesShu Chuen Li
Breast Cancer (Tokyo, Japan)|May 27, 2018
Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluationLan Gao, Shu-Chuen Li
Applied Health Economics and Health Policy|December 12, 2018
Modelled Economic Evaluation of Nivolumab for the Treatment of Second-Line Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer in Australia Using Both Partition Survival and Markov ModelsLan Gao, Shu-Chuen Li
Journal of Medical Economics|May 6, 2011
Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID studyShu Chuen Li, Sanjay Kumar Aggarwal
Annals of the Academy of Medicine, Singapore|December 12, 2007
Sociodemographic factors influencing the effectiveness of public health education - a comparison of two studies in SingaporeHwee-Lin Wee, Shu-Chuen Li
World Journal of Gastroenterology|March 6, 2015
Treatment of irritable bowel syndrome in China: a reviewChun-Yan Li, Shu-Chuen Li
Seminars in Arthritis and Rheumatism|March 14, 2007
True difference or something else? Problems in cost of osteoarthritis studiesFeng Xie, Julian Thumboo, Shu-Chuen Li
Therapeutic Innovation & Regulatory Science|September 22, 2018
Analysis of the Utilization Status of Essential Medicines in Beijing's Community Health InstitutionsFang Zhang, Yu Yang, Shu Chuen Li
Value in Health Regional Issues|April 27, 2018
How Quality of Life as Patient-Reported Outcome Has Been Studied for Rheumatoid Arthritis in Chinese-Speaking PopulationHao Hu, Luan Luan, Shu-Chuen Li
Seminars in Arthritis and Rheumatism|June 9, 2005
Do health-related quality-of-life domains and items in knee and hip osteoarthritis vary in importance across social-cultural contexts? A qualitative systematic literature reviewFeng Xie, Shu-Chuen Li, Julian Thumboo
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Expert Opinion on Pharmacotherapy|July 31, 2007
How to improve pharmacoeconomic data generalisability between different countriesShu Chuen Li
Breast Cancer (Tokyo, Japan)|May 27, 2018
Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluationLan Gao, Shu-Chuen Li
Applied Health Economics and Health Policy|December 12, 2018
Modelled Economic Evaluation of Nivolumab for the Treatment of Second-Line Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer in Australia Using Both Partition Survival and Markov ModelsLan Gao, Shu-Chuen Li
Journal of Medical Economics|May 6, 2011
Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID studyShu Chuen Li, Sanjay Kumar Aggarwal
Annals of the Academy of Medicine, Singapore|December 12, 2007
Sociodemographic factors influencing the effectiveness of public health education - a comparison of two studies in SingaporeHwee-Lin Wee, Shu-Chuen Li
World Journal of Gastroenterology|March 6, 2015
Treatment of irritable bowel syndrome in China: a reviewChun-Yan Li, Shu-Chuen Li
Seminars in Arthritis and Rheumatism|March 14, 2007
True difference or something else? Problems in cost of osteoarthritis studiesFeng Xie, Julian Thumboo, Shu-Chuen Li
Therapeutic Innovation & Regulatory Science|September 22, 2018
Analysis of the Utilization Status of Essential Medicines in Beijing's Community Health InstitutionsFang Zhang, Yu Yang, Shu Chuen Li
Value in Health Regional Issues|April 27, 2018
How Quality of Life as Patient-Reported Outcome Has Been Studied for Rheumatoid Arthritis in Chinese-Speaking PopulationHao Hu, Luan Luan, Shu-Chuen Li
Seminars in Arthritis and Rheumatism|June 9, 2005
Do health-related quality-of-life domains and items in knee and hip osteoarthritis vary in importance across social-cultural contexts? A qualitative systematic literature reviewFeng Xie, Shu-Chuen Li, Julian Thumboo
Pageof 13